Fifteen years of navigating the intersection of clinical science, regulatory strategy, and global market dynamics — now applied exclusively to the companies reshaping healthcare through technology.

The gap between a breakthrough MedTech innovation and a commercially successful product is rarely a technical one. It is strategic — a failure to navigate regulatory complexity, misread market dynamics, or build the right institutional relationships at the right time.
Our founder has spent 15 years closing that gap. Beginning in regulatory affairs for a global medical device OEM in the United States, the career trajectory moved through market access strategy in India, digital health commercialization across Southeast Asia, and ultimately to founding an independent advisory practice at the frontier of AI-driven healthcare.
This breadth is not accidental. It reflects a deliberate philosophy: that the most valuable strategic advice comes from advisors who have operated inside the systems they counsel — who have sat across the table from FDA reviewers, hospital procurement committees, and Series B investors simultaneously.
Today, that experience is applied to a focused set of engagements with MedTech startups, healthcare AI companies, and the investors who back them — with a singular focus on translating technical innovation into durable commercial outcomes.
Managed FDA 510(k) submissions and clinical evidence strategies for Class II and III medical devices. Built cross-functional teams bridging R&D, clinical, and commercial functions.
Led market entry strategies for 12 MedTech companies entering the Indian subcontinent. Developed reimbursement frameworks and hospital procurement strategies across public and private health systems.
Scaled a digital health platform across Singapore, Malaysia, Thailand, and Indonesia. Negotiated partnerships with 30+ hospital networks and secured Series B funding through investor-ready commercial strategy.
Founded an independent advisory practice focused on AI-driven healthcare, surgical robotics, and global market access. Serving MedTech startups, healthcare AI companies, and institutional investors across three continents.
Every engagement is structured around measurable outcomes — regulatory clearance timelines, market entry milestones, partnership agreements, and revenue targets.
Our advisory is informed by direct operational experience across the US, India, and Southeast Asia — not just theoretical market knowledge.
We speak the language of clinicians, regulators, and investors with equal fluency — bridging the communication gap that often stalls MedTech commercialization.
Strategic recommendations are grounded in rigorous analysis of clinical evidence, competitive intelligence, and regulatory precedent.